These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22300406)

  • 61. [Advances in the research on Alzheimer's disease--overview].
    Tsuji S
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1093-4. PubMed ID: 9577653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.
    Sambamurti K; Suram A; Venugopal C; Prakasam A; Zhou Y; Lahiri DK; Greig NH
    Curr Alzheimer Res; 2006 Feb; 3(1):81-90. PubMed ID: 16472208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development and characterization of an aged onset model of Alzheimer's disease in Drosophila melanogaster.
    Mhatre SD; Michelson SJ; Gomes J; Tabb LP; Saunders AJ; Marenda DR
    Exp Neurol; 2014 Nov; 261():772-81. PubMed ID: 25173219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.
    Stefanova NA; Muraleva NA; Korbolina EE; Kiseleva E; Maksimova KY; Kolosova NG
    Oncotarget; 2015 Jan; 6(3):1396-413. PubMed ID: 25595891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New Insights into the Molecular Bases of Familial Alzheimer's Disease.
    D'Argenio V; Sarnataro D
    J Pers Med; 2020 Apr; 10(2):. PubMed ID: 32325882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A critical analysis of the 'amyloid cascade hypothesis'.
    Armstrong RA
    Folia Neuropathol; 2014; 52(3):211-25. PubMed ID: 25310732
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.
    Zis P; Strydom A
    Free Radic Biol Med; 2018 Jan; 114():3-9. PubMed ID: 28870521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nature Versus Nurture: Does Proteostasis Imbalance Underlie the Genetic, Environmental, and Age-Related Risk Factors for Alzheimer's Disease?
    Kikis EA
    Healthcare (Basel); 2017 Aug; 5(3):. PubMed ID: 28829364
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Alzheimer's disease - history of failures - a short opinion on the contemporary status of research].
    Stępkowski D
    Postepy Biochem; 2019 Nov; 65(4):322-324. PubMed ID: 31945288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
    Chen ZY; Zhang Y
    Zool Res; 2022 Nov; 43(6):1026-1040. PubMed ID: 36317468
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease.
    Hogan R; Flamier A; Nardini E; Bernier G
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ozone and Particulate Matter Exposure and Alzheimer's Disease: A Review of Human and Animal Studies.
    Liu RM; Chong Z; Chen JC
    J Alzheimers Dis; 2020; 76(3):807-824. PubMed ID: 32568209
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endogenous recapitulation of Alzheimer's disease neuropathology through human 3D direct neuronal reprogramming.
    Sun Z; Kwon JS; Ren Y; Chen S; Cates K; Lu X; Walker CK; Karahan H; Sviben S; Fitzpatrick JAJ; Valdez C; Houlden H; Karch CM; Bateman RJ; Sato C; Mennerick SJ; Diamond MI; Kim J; Tanzi RE; Holtzman DM; Yoo AS
    bioRxiv; 2023 May; ():. PubMed ID: 37292658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases.
    Rahman MA; Rahman MS; Uddin MJ; Mamum-Or-Rashid ANM; Pang MG; Rhim H
    Environ Sci Pollut Res Int; 2020 Dec; 27(36):44659-44672. PubMed ID: 32201908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.
    Bakulski KM; Rozek LS; Dolinoy DC; Paulson HL; Hu H
    Curr Alzheimer Res; 2012 Jun; 9(5):563-73. PubMed ID: 22272628
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases.
    Monnet-Tschudi F; Zurich MG; Boschat C; Corbaz A; Honegger P
    Rev Environ Health; 2006; 21(2):105-17. PubMed ID: 16898674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of environmental contaminants in the etiology of Alzheimer's disease: a review.
    Yegambaram M; Manivannan B; Beach TG; Halden RU
    Curr Alzheimer Res; 2015; 12(2):116-46. PubMed ID: 25654508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting epigenetics: A novel promise for Alzheimer's disease treatment.
    Jeremic D; Jiménez-Díaz L; Navarro-López JD
    Ageing Res Rev; 2023 Sep; 90():102003. PubMed ID: 37422087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.